SCHEMBL30879020

SCHEMBL30879020

C#Cc1c(-c2ccccc2Cl)c(=O)n(C)c2nc(Nc3ccc(N(C)CCNC)cc3)ncc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WEE1 P30291 8/20 0.56
RIPK2 O43353 2/20 0.46
ACVR1 Q04771 2/20 0.46
NOD2 Q9HC29 2/20 0.46
FGFR1 P11362 9/20 0.45
SRC P12931 10/20 0.45
EGFR P00533 4/20 0.45
FGFR2 P21802 2/20 0.45
FGFR4 P22455 2/20 0.45
FGFR3 P22607 2/20 0.45
PDGFRB P09619 9/20 0.44
PDGFRA P16234 9/20 0.44
ABL1 P00519 8/20 0.44
MAPK14 Q16539 8/20 0.44
KIT P10721 3/20 0.43
CHEK1 O14757 1/20 0.42
JAK2 O60674 1/20 0.42
PRKD3 O94806 1/20 0.42
MAP4K4 O95819 1/20 0.42
PAK4 O96013 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878325 0.92 WEE1 (0.58) WEE1RIPK2ACVR1NOD2FGFR1
SCHEMBL30878465 0.84 WEE1 (0.77) WEE1FGFR1SRCEGFRFGFR2
SCHEMBL30878380 0.84 WEE1 (0.48) WEE1FGFR1SRCEGFRFGFR2
SCHEMBL30878400 0.83 FGFR1 (0.53) WEE1RIPK2ACVR1NOD2FGFR1
SCHEMBL30878331 0.83 WEE1 (0.69) WEE1RIPK2ACVR1NOD2FGFR1
SCHEMBL30878444 0.82 FGFR1 (0.49) WEE1ACVR1FGFR1SRCEGFR
SCHEMBL30878365 0.82 FGFR1 (0.47) WEE1ACVR1FGFR1SRCEGFR
SCHEMBL30879233 0.82 WEE1 (0.52) WEE1RIPK2ACVR1NOD2FGFR1
SCHEMBL30878353 0.82 FGFR4 (0.47) WEE1RIPK2ACVR1NOD2FGFR1
SCHEMBL30878454 0.81 FGFR1 (0.51) WEE1RIPK2ACVR1NOD2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed